Flecainide-induced myalgias and weakness: a rare adverse reaction
Dilpat Kumar1, Muhammad Ebad Rehman1, Tracey Mersfelder2
1Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA.
Flecainide, an antiarrhythmic drug, can rarely cause muscle pain (myalgias) and chest discomfort. Discontinuing flecainide quickly resolved these symptoms in a patient with atrial fibrillation.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Flecainide is a Class 1C antiarrhythmic agent.
- Adverse reactions, both cardiac and non-cardiac, are known side effects of flecainide therapy.
More Related Videos
08:33Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
